![Toxics | Free Full-Text | The NOAEL Metformin Dose Is Ineffective against Metabolic Disruption Induced by Chronic Cadmium Exposure in Wistar Rats Toxics | Free Full-Text | The NOAEL Metformin Dose Is Ineffective against Metabolic Disruption Induced by Chronic Cadmium Exposure in Wistar Rats](https://pub.mdpi-res.com/toxics/toxics-06-00055/article_deploy/html/images/toxics-06-00055-ag.png?1570457635)
Toxics | Free Full-Text | The NOAEL Metformin Dose Is Ineffective against Metabolic Disruption Induced by Chronic Cadmium Exposure in Wistar Rats
A PROPOSAL FOR CALCULATING THE NO-OBSERVED-ADVERSE-EFFECT LEVEL (NOAEL) FOR ORGANIC COMPOUNDS RESPONSIBLE FOR LIVER TOXICITY BA
![Calculation of the FIH dose from MABEL and NOAEL. The FIH dose from... | Download Scientific Diagram Calculation of the FIH dose from MABEL and NOAEL. The FIH dose from... | Download Scientific Diagram](https://www.researchgate.net/publication/362094303/figure/fig5/AS:1179749443469337@1658285594298/Calculation-of-the-FIH-dose-from-MABEL-and-NOAEL-The-FIH-dose-from-MABEL-and-NOAEL-The_Q320.jpg)
Calculation of the FIH dose from MABEL and NOAEL. The FIH dose from... | Download Scientific Diagram
Do Similar Structures Have Similar No Observed Adverse Effect Level (NOAEL) Values? Exploring Chemoinformatics Approaches for Estimating NOAEL Bounds and Uncertainties | Chemical Research in Toxicology
![Calculation of the FIH dose from MABEL and NOAEL. The FIH dose from... | Download Scientific Diagram Calculation of the FIH dose from MABEL and NOAEL. The FIH dose from... | Download Scientific Diagram](https://www.researchgate.net/publication/362094303/figure/fig5/AS:1179749443469337@1658285594298/Calculation-of-the-FIH-dose-from-MABEL-and-NOAEL-The-FIH-dose-from-MABEL-and-NOAEL-The.png)
Calculation of the FIH dose from MABEL and NOAEL. The FIH dose from... | Download Scientific Diagram
![Determination of starting dose of the T cell-redirecting bispecific antibody ERY974 targeting glypican-3 in first-in-human clinical trial | Scientific Reports Determination of starting dose of the T cell-redirecting bispecific antibody ERY974 targeting glypican-3 in first-in-human clinical trial | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-16564-x/MediaObjects/41598_2022_16564_Fig1_HTML.png)